Cervical cancer is one of the leading causes of cancer-related deaths among women worldwide. Despite being highly preventable and treatable when detected early, many cases go undiagnosed due to limited access to proper screening, lack of awareness, and delays in medical consultation. Traditional screening methods, such as Pap smears and HPV tests, while effective, can be time-consuming, resource-intensive, and subject to human error.
CerviScan addresses these critical challenges by leveraging ensemble machine learning models to provide fast, accurate, and automated cervical cancer detection. Our AI-powered platform analyzes medical images with high precision, reducing diagnostic errors and ensuring that abnormalities are detected at the earliest stage possible. By integrating multiple deep learning models, our system improves classification accuracy, minimizing false positives and negatives, which are common limitations in single-model approaches. One of the biggest barriers to cervical cancer screening is accessibility. Many women in remote or underserved areas lack access to healthcare facilities equipped with specialized diagnostic tools. CerviScan bridges this gap by offering an easy-to-use web-based solution where users and healthcare professionals can upload medical images for instant analysis. This democratizes access to cutting-edge technology, making early detection possible for everyone, regardless of location. Another major issue is the delay in diagnosis. Traditional pathology labs often take days or even weeks to deliver results, during which time the disease could progress. CerviScan significantly reduces this waiting time, providing rapid preliminary results that allow patients to seek medical attention sooner. This not only improves survival rates but also eases the burden on healthcare systems by prioritizing high-risk cases for further evaluation.